Key result
Obstructive sleep apnea is linked to resistant hypertension, with CPAP as the primary treatment.
Answers are grounded in this paper and cite their sources.
Obstructive sleep apnea syndrome is caused by upper airway collapse during inspiration, causing intermittent hypoxemia, hypercapnia, acidosis, sympathetic nervous system activation, and arousal from sleep. Nighttime blood pressure is higher, but unexpectedly, daytime hypertension occurs. The prevalence of hypertension is very high and the incidence of hypertension increases as the number of apneic and hypopneic events per hour rises. Obesity is a major predisposing factor for the development of obstructive sleep apnea. Daytime sleepiness, snoring, and breathing pauses are important symptoms to elicit from the patient or sleep partner. Resistant hypertension is an important clue. Overnight polysomnography is required for diagnosis. Weight loss, avoidance of nocturnal sedatives, cessation of evening alcohol ingestion, and avoidance of the supine position during sleep are initial therapeutic actions in mild obstructive sleep apnea syndrome. Continuous positive airway pressure is the treatment of choice for patients unable to find relief from lifestyle changes. Blood pressure modestly improves with treatment.
No takes yet. Share an insight, caveat, or question.
Prisant et al. (2006) conducted a review in Obstructive sleep apnea syndrome. Continuous positive airway pressure and lifestyle modifications was evaluated. Obstructive sleep apnea is strongly associated with daytime and resistant hypertension, with continuous positive airway pressure serving as the treatment of choice when lifestyle changes are insufficient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: